Apoptosis in Health and Disease - Part B Advances in Protein Chemistry and Structural Biology Series
Coordonnateur : Donev Rossen
Apoptosis in Health and Disease - Part B, Volume 126 in the Advances in Protein Chemistry and Structural Biology focuses on apoptotic responses in numerous conditions - from bacterial and parasite infections, to pathological states such as oxidative stress, pulmonary hypertension, and different cancer types, etc. In addition, the book provides therapeutic strategies for targeting apoptosis. These new advanced understandings are playing a major influence in drug discovery and the introduction of new therapies that target the cell death process.
Apoptosis, or programmed cell death, is the mechanism by which cells die either physiologically or pathologically. Vast research in apoptosis has advanced our understanding of basic physiological and pathological processes occurring in cells, organs and organisms, and its role in a number of diseases.
Santi Prasad Sinha Babu
Soundarapandian KANNAN
Soundarapandian KANNAN
Dayanidhi Raman
Gautam Sethi
Mohammad Abid
Pankaj Taneja
Anupam Bishayee
Harikumar KB
Natella Enukashvily
Sadhana R. Joshi
Ali Akbar Moosavi-Movahedi
- Integrates experimental and computational methods for studying apoptosis in health and different diseases
- Includes strategies for identification of suitable therapeutic targets
- Discusses the design of treatments targeting key points in the apoptotic cascade
Date de parution : 06-2021
Ouvrage de 356 p.
15.2x22.8 cm
Thèmes d’Apoptosis in Health and Disease - Part B :
Mots-clés :
Amyloid structure; Apoptosis; Apoptosis resistance; Autophagy; Bcl-2; Biocondensates; Biocondensates seeding by RNA; Bioenergetics; Biomarker; Biophysical techniques; Biothermodynamics; CagA; Calcium signaling; Cancer; Caspase; CCR5; Cell death; Coacervates; Conformational diseases; Cytochrome c; Detecting apoptosing retinal cells; ER-mitochondria contact sites; Folding mechanisms; FXR; Gene editing; Gestational diabetes mellitus; Hematopoietic stem cells; Hemolysin; HIV; Immunosuppression; Inflammatory diseases; Intrauterine growth restriction; Liquid; Liquid phase separation; Long non-coding RNA; MAMs; Membraneless organelles; Mesenchymal stem cells; Molecular chaperons; Molten globule; Mutation; Neurodegeneration; Neurodegenerative diseases; Nf-kB; Non-apoptotic cell death; Non-programmed cell death; Organelle tethering; Pathogenic bacteria; Pericentromere; Phagocytosis; Preeclampsia; Programmed cell death; Protein folding; Regeneration; Regulated cell death; Retinal disease; Tandemly repeated RNA; Therapy; TLR